These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32021247)

  • 1. miR-520b Promotes Breast Cancer Stemness Through Hippo/YAP Signaling Pathway.
    Zhang H; Lang TY; Zou DL; Zhou L; Lou M; Liu JS; Li YZ; Ding DY; Li YC; Zhang N; Zheng XD; Zeng XH; Zhou Q; Li L
    Onco Targets Ther; 2019; 12():11691-11700. PubMed ID: 32021247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPRU, As A Tumor Suppressor, Inhibits Cancer Stemness By Attenuating Hippo/YAP Signaling Pathway.
    Gu J; Zhang Z; Lang T; Ma X; Yang L; Xu J; Tian C; Han K; Qiu J
    Onco Targets Ther; 2019; 12():8095-8104. PubMed ID: 31632062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SKP1 promotes YAP-mediated colorectal cancer stemness via suppressing RASSF1.
    Tian C; Lang T; Qiu J; Han K; Zhou L; Min D; Zhang Z; Qi D
    Cancer Cell Int; 2020 Dec; 20(1):579. PubMed ID: 33292299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-520b as a novel molecular target for suppressing stemness phenotype of head-neck cancer by inhibiting CD44.
    Lu YC; Cheng AJ; Lee LY; You GR; Li YL; Chen HY; Chang JT
    Sci Rep; 2017 May; 7(1):2042. PubMed ID: 28515423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX2 maintains the stemness of retinoblastoma stem-like cells through Hippo/YAP signaling pathway.
    Zhao N; Zhou L; Lu Q; Wang S; Sun Y; Ding Y; Liu M; He H; Lang T
    Exp Eye Res; 2022 Jan; 214():108887. PubMed ID: 34890603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of
    Zhu Q; Yuan J; He Y; Hu Y
    J Oncol; 2021; 2021():5170496. PubMed ID: 34659411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
    Wang C; Yin W; Liu H
    J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-520b Inhibits IGF-1R to Increase Doxorubicin Sensitivity and Promote Cell Apoptosis in Breast Cancer.
    Zhang H; Zheng XD; Zeng XH; Li L; Zhou Q
    Yakugaku Zasshi; 2021 Mar; 141(3):415-426. PubMed ID: 33116033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-103a Curtails the Stemness of Non-Small Cell Lung Cancer Cells by Binding OTUB1 via the Hippo Signaling Pathway.
    Hu Z; Xiao D; Qiu T; Li J; Liu Z
    Technol Cancer Res Treat; 2020; 19():1533033820971643. PubMed ID: 33174524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8.
    Hu N; Zhang J; Cui W; Kong G; Zhang S; Yue L; Bai X; Zhang Z; Zhang W; Zhang X; Ye L
    J Biol Chem; 2011 Apr; 286(15):13714-22. PubMed ID: 21343296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-520b inhibits proliferation, migration and invasion in gallbladder carcinoma by targeting RAB22A.
    Zhou J; Gao F; Zhang H; Xing M; Xu Z; Zhang R
    Arch Med Sci; 2021; 17(2):481-491. PubMed ID: 33747283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CARF, As An Oncogene, Promotes Colorectal Cancer Stemness By Activating ERBB Signaling Pathway.
    Dong W; Cao Z; Pang Y; Feng T; Tian H
    Onco Targets Ther; 2019; 12():9041-9051. PubMed ID: 31802911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway.
    Xu J; Fang X; Long L; Wang S; Qian S; Lyu J
    Cancer Biol Ther; 2021 Jan; 22(1):5-11. PubMed ID: 33307962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of miR-520b promotes ovarian cancer growth.
    Guan R; Cai S; Sun M; Xu M
    Oncol Lett; 2017 Sep; 14(3):3155-3161. PubMed ID: 28927060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3'UTR of CD46.
    Cui W; Zhang Y; Hu N; Shan C; Zhang S; Zhang W; Zhang X; Ye L
    Cancer Biol Ther; 2010 Aug; 10(3):232-41. PubMed ID: 20574151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.
    Asaduzzaman M; Constantinou S; Min H; Gallon J; Lin ML; Singh P; Raguz S; Ali S; Shousha S; Coombes RC; Lam EW; Hu Y; Yagüe E
    Breast Cancer Res Treat; 2017 Jun; 163(3):461-474. PubMed ID: 28341962
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Hu B; Xian Z; Zou Q; Zhang D; Su D; Yao J; Ren D
    Cancer Biother Radiopharm; 2021 Feb; 36(1):45-57. PubMed ID: 32379550
    [No Abstract]   [Full Text] [Related]  

  • 20. MicroRNA-520b Functions as a Tumor Suppressor in Colorectal Cancer by Inhibiting Defective in Cullin Neddylation 1 Domain Containing 1 (DCUN1D1).
    Xiao J; Li G; Zhou J; Wang S; Liu D; Shu G; Zhou J; Ren F
    Oncol Res; 2018 May; 26(4):593-604. PubMed ID: 28470146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.